Genetic synchronization of the brain and liver molecular clocks defend against chrono-metabolic disease
- PMID: 39665757
- PMCID: PMC11665897
- DOI: 10.1073/pnas.2417678121
Genetic synchronization of the brain and liver molecular clocks defend against chrono-metabolic disease
Abstract
Nearly every cell of the body contains a circadian clock mechanism that is synchronized with the light-entrained clock in the suprachiasmatic nucleus (SCN). Desynchrony between the SCN and the external environment leads to metabolic dysfunction in shift workers. Similarly, mice with markedly shortened endogenous period due to the deletion of circadian REV-ERBα/β nuclear receptors in the SCN (SCN DKO) exhibit increased sensitivity to diet-induced obesity (DIO) on a 24 h light:dark cycle while mice with REV-ERBs deleted in hepatocytes (HepDKO) display exacerbated hepatosteatosis in response to a high-fat diet. Here, we show that inducing deletion of hepatocyte REV-ERBs in SCN DKO mice (Hep-SCN DDKO) rescued the exacerbated DIO and hepatic triglyceride accumulation, without affecting the shortened behavioral period. These findings suggest that metabolic disturbances due to environmental desynchrony with the central clock are due to effects on peripheral clocks which can be mitigated by matching peripheral and central clock periods even in a desynchronous environment. Thus, maintaining synchrony within an organism, rather than between endogenous and exogenous clocks, may be a viable target for the treatment of metabolic disorders associated with circadian disruption.
Keywords: REV-ERB; circadian rhythms; metabolism; obesity; suprachiasmatic Nucleus.
Conflict of interest statement
Competing interests statement:M.A.L. is on the advisory board and has received research funding unrelated to these studies from Pfizer, and serves on the advisory board and is co-founder of Flare Therapeutics.
Figures
References
-
- Patke A., Young M. W., Axelrod S., Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol. 21, 67–84 (2019). - PubMed
MeSH terms
Substances
Grants and funding
- R01 DK045586/DK/NIDDK NIH HHS/United States
- DK128984/HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- F32 DK128984/DK/NIDDK NIH HHS/United States
- DK45586/HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- P30 DK019525/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
